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Introduction
Tuberculosis (TB) remains the leading cause of morbidity and mortality from infectious disease worldwide. 1 It is associated with chronic, persistent antigen stimulation in vivo that maintains sustained immune responses that suppress, but generally fail to eradicate, the pathogen Mycobacterium tuberculosis. Knowledge of the immunopathogenesis of TB remains incomplete. Acquired cellular immunity has been demonstrated in classical experiments with mice in which the participation of specifically sensitized Tlymphocytes and mononuclear phagocytes has been reported. 2 Protective cellular immunity against TB is mediated by CD4 + T-lymphocytes 2 with support from CD8 + T-lymphocytes. 3 The CD4 + T-cells secrete cytokines, such as interferon-γ (IFN-γ), which activate macrophages to destroy the bacteria with which they are infected. Some CD4 + T-cells also act as cytotoxic effector cells that *YE Wu and SW Zhang contributed equally to this research and are co-first authors. Peripheral blood lymphocyte subsets in pulmonary tuberculosis can directly destroy the infected target cells. 4 -6 Natural killer (NK) cells are a CD16 + CD56 + CD3lymphocyte subpopulation that plays an important role in the early phase of immune responses against a variety of viruses, parasites and microbial pathogens by exhibiting cytotoxic functions and secreting numerous cytokines. 7 They do not require prior activation in order to kill target cells that are missing the major complex of histocompatibility. NK cells may provide innate protection against M. tuberculosis. It has been reported that NK cells may mediate the killing of intracellular M. tuberculosis via apoptosis. 8 CD152, also known as cytotoxic T-lymphocyte antigen 4 (CTLA-4), and CD28 are two homologous costimulatory molecules that bind to the same costimulatory ligands on antigenpresenting cells, B7-1 (CD80) and B7-2 (CD86), but have different functions during T-cell activation. CD152 is constitutively expressed on naive CD4 + T-cells, while the expression of CD28 is induced upon T-cell activation. Triggering of CD28 strongly upregulates interleukin-2 production, T-cell proliferation and cell cycle progression. 9 In contrast, CD152 is a major down-regulator of immune responses. 10, 11 The CD95 ligand molecule is not found on resting T-cells, but its expression increases during T-cell activation, whereupon it can cross-link to CD95 + cells, leading to apoptosis of T-cells. 12 -17 Despite the important roles of lymphocytes in antimicrobial immunity, very few studies have been performed to evaluate changes in the peripheral blood in TB patients. The aim of the present study was to investigate the changes in lymphocytes subpopulations in patients with active TB in order to increase knowledge of the immunological changes that occur during the pathogenesis of TB in humans.
Patients and methods

PATIENTS
In this observational study, patients with newly diagnosed pulmonary TB, with a smear positive for acid-fast bacilli, were recruited from the Third People's Hospital of Shantou City, Guangdong, China, between January 2007 and December 2008. The diagnosis of TB was confirmed by positive culture for M. tuberculosis. Purified protein derivative-positive healthy subjects were used as controls. All subjects enrolled in the study were negative for human immunodeficiency virus (HIV). The study protocol was approved by the Institutional Review Board for Human Studies of the Third People's Hospital of Shantou City, and informed consent was obtained from all the study participants.
SPECIMEN COLLECTION AND PREPARATION
Fasting venous blood samples (2 ml) were taken before breakfast and collected into tubes containing anticoagulant (ethylenediaminetetra-acetic acid dipotassium salt). All samples from the TB patients were taken before treatment.
FLOW CYTOMETRY
Samples of venous blood were vortexed and 100 µl of whole blood were added to 12 × 75 mm plastic tubes. The cells were then stained with control isotopic antibodies immunoglobulin (Ig) G1-fluorescein isothiocyanate (FITC) and IgG1-phycoerythrin (PE) or two-colour combinations of mouse monoclonal antibodies (20 µl/test) as follows:
CD19-PE, CD4-FITC/CD28-PE, CD4-FITC/CD152-PE, CD8-FITC/CD28-PE and CD8-FITC/CD152-PE (Beckman Coulter, Los Angeles, CA, USA). IgG1-PE and IgG1-FITC were used at YE Wu, SW Zhang, WG Peng et al.
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concentrations equal to that of the examined probes. After incubation for 30 min in the dark at room temperature, the probes were lysed and fixed with ImmunoPrep ® reagents (Beckman Coulter) using a Q-Prep™ Immunology Workstation (Beckman Coulter).
DATA ACQUISITION AND ANALYSIS
Listmode data were acquired from an Epics ® XL™ Flow Cytometer (Beckman Coulter) and analysed using WinList™ software, version 3.0 (Beckman Coulter). The lymphocyte gate was generated using a forward-and sideangle scattered light window leucogate. Dot plots of representative samples from the gate with cell surface antigens CD3, CD4, CD8, CD19, CD(16+56), CD28 and CD152 were then performed. Typically, 10 000 events were acquired in the gating region. The threshold for positive cells was determined by removing the background staining obtained from isotype-matched control antibodies for each sample.
STATISTICAL ANALYSIS
Data were reported as the mean ± SD. Statistical analysis was performed using the SPSS ® statistical package, version 12.0 (SPSS Inc., Chicago, IL, USA) for Windows ® . Differences between the mean lymphocyte populations of the TB and control groups were analysed using the independent sample t-test. A P-value of < 0.05 was considered to be statistically significant.
Results
A total of 21 patients with pulmonary TB were enrolled in the study, with a mean ± SD age of 50 ± 15 years; 14 were male and seven were female. Fifteen healthy subjects with mean ± SD age of 48 ± 13 years (10 male and five female) were used as controls. The age range of all the study participants was 18 -79 years.
Using flow cytometry analysis, it was shown that patients with TB had a significantly decreased percentage of CD3 + T-cells (64.22 ± 8.09% versus 72.19 ± 2.84%, P < 0.001) and CD3 + CD4 + T-helper cells (31.93 ± 5.02% versus 41.93 ± 2.30%, P = 0.005), and a significantly decreased ratio of CD3 + CD4 + T-helper cells to CD3 + CD8 + cytotoxic T-cells (1.08 ± 0.29 versus 1.60 ± 0.10, P = 0.003) compared with healthy controls (Fig. 1) . In contrast, the proportion of CD3 + CD8 + cells was significantly increased in active TB patients compared with healthy controls (31.10 ± 7.86% versus 26.21 ± 1.11%, P < 0.001) ( Fig. 1) . Patients with TB also had a significantly increased percentage of CD19 + B-cells compared with controls (17.43 ± 9.89% versus 12.19 ± 2.98%, P = 0.003) (Fig. 2) . There was no significant difference in the proportion of CD3 -CD(16+56) + NK cells between the two groups (Fig. 2) .
The proportion of CD28 + cells (59.08 ± 11.09% versus 51.77 ± 4.12%, P = 0.001), CD152 + cells (9.32 ± 8.35% versus 0.36 ± 0.28%, P < 0.001) and subpopulations of CD4 + CD152 + (4.00 ± 4.00% versus 0.11 ± 0.06%, P < 0.001), CD8 + CD28 + (16.63 ± 6.73% versus 13.50 ± 3.77%, P = 0.019) and CD8 + CD152 + (3.06 ± 3.48% versus 0.19 ± 0.24%, P < 0.001) cells were significantly increased in TB patients compared with healthy controls (Figs 2 and 3) . The proportion of CD4 + CD28 + cells in patients with active TB was not significantly different to that in healthy controls (Fig. 3 ).
Discussion
Human cell-mediated immunity to M. tuberculosis is assumed to involve the ability of lymphocytes to activate infected mononuclear phagocytes, resulting in the killing of intracellular bacilli. The percentages of CD3 + and CD3 + CD4 + cells, and the ratio of CD3 + CD4 + to CD3 + CD8 + cells, were significantly lower, while the Peripheral blood lymphocyte subsets in pulmonary tuberculosis percentages of CD152 + , CD4 + CD152 + , CD8 + CD152 + , CD28 + and CD8 + CD28 + cells were significantly higher in TB patients compared with healthy controls in the present study. These results suggested a relative lymphopenia in TB patients.
T-lymphocyte subsets, particularly CD4 + cells, are critical in immunity against M. tuberculosis infection. 12 CD4 + T-lymphocytes play two important roles in TB infection: first, to produce cytokines that govern the cellmediated immune responses; and secondly, to eliminate the infected macrophages via apoptosis. CD8 + cytotoxic T-cells are an important source of IFN-γ and may also kill bacteria via cytotoxic mechanisms. 13 -15 A previous study by Belkaid and Rouse 16 showed that CD4 + T-helper cells are very important in the control of TB. Few studies have been performed, however, to evaluate the changes in T-lymphocyte subsets in the peripheral blood of TB patients. Jones et al. 17 demonstrated that CD4 + T-cells were reduced while CD8 + cells were increased in TB patients. In other studies, the quantity of CD4 + cells was decreased while the quantity of CD8 + cells was unchanged compared with controls. 18 -20 There was a decrease in total Tlymphocytes (CD3 + cells) and CD3 + CD4 + cells in TB patients compared with control subjects in the present study. There was also a decrease in the ratio of CD3 + CD4 + to CD3 + CD8 + cells. This decreased ratio could be due to either a decreased percentage of CD4 + cells or an increased percentage of CD8 + cells. Thus, lymphocyte subsets may have an important role in immunity against TB. Although decreased CD4 + T-cell counts and changes in CD8 + cell counts are pivotal immune abnormalities in HIV patients, TB may be a cause of non-HIV-associated CD4 + lymphopenia. 21 The role of B-cells during M. tuberculosis infection is not clear. In the present study, the percentage of CD19 + B-cells was significantly increased in TB patients compared with controls, which is different from data reported in a previous study by Montes Santiago et al. 22 However, Corominas et al. 23 found a decrease in Bcells in TB patients. Thus, B-cell participation in M. tuberculosis infection needs further study. With regard to NK cells, in the present study there was no difference in the percentage of NK cells between TB patients and control subjects. This is in contrast to a previous study in which the quantity of NK cells increased in TB patients compared with controls. 24 Despite these discrepancies in the counts of NK cells in TB patients, NK cells seem to play an important role in immunity against TB.
CTLA-4 (CD152) is expressed on activated CD4 + and CD8 + T-cells and binds to the costimulatory ligands B7-1 (CD80) and B7-2 (CD86) with a 20-fold higher affinity than CD28. 25, 26 In contrast to CD28, which is constitutively expressed on T-lymphocytes, CTLA-4 is rapidly up-regulated after the activation of T-lymphocytes and is a negative regulator of T-cell activation. 27 Once CTLA-4 is up-regulated, the inhibitory B7-CTLA-4 interaction predominates, leading to the termination of T-lymphocyte activation. 28 Data from the present study showed that the quantities of CD152 + cells and CD28 + cells were significantly higher in patients with TB compared with healthy control subjects. Further analysis of the CD152 + and CD28 + subpopulations showed that CD152 was significantly up-regulated in both CD4 + and CD8 + cells and CD28 was significantly up-regulated in CD8 + cells in TB patients. Engelhardt et al. 29 indicated that CTLA-4 overexpression inhibits the responses of CD4 + T-cells, which may partially explain the decrease in CD4 + cells in TB patients. In contrast, Gong et al. 30 reported that CTLA-4 but not CD28 expression is depressed in TB patients. The increased expression of CTLA-4 on lymphocytes responding to M. tuberculosis indicated, in part, that cellular immune function was depressed in TB patients.
The results of the present study demonstrate that the immune responses against M. tuberculosis are complicated and interactions between all the cellular elements are essential to the anti-infection processes. All of the parameters studied here have the potential to be non-invasive clinical indictors for the early detection and management of TB.
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